Cargando…

Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded

This study was conducted to explore a bibliometric approach to quantitatively assess current research trends in cisplatin-containing chemotherapy for small cell lung cancer (SCLC), using related literature in the Science Citation Index Expanded database from 1992 to 2011. Articles were analyzed by t...

Descripción completa

Detalles Bibliográficos
Autores principales: HO, YUH-SHAN, NAKAZAWA, KENSUKE, SATO, SHINYA, TAMURA, TOMOHIRO, KURISHIMA, KOICHI, SATOH, HIROAKI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573148/
https://www.ncbi.nlm.nih.gov/pubmed/23420619
http://dx.doi.org/10.3892/ol.2012.1029
_version_ 1782259414961487872
author HO, YUH-SHAN
NAKAZAWA, KENSUKE
SATO, SHINYA
TAMURA, TOMOHIRO
KURISHIMA, KOICHI
SATOH, HIROAKI
author_facet HO, YUH-SHAN
NAKAZAWA, KENSUKE
SATO, SHINYA
TAMURA, TOMOHIRO
KURISHIMA, KOICHI
SATOH, HIROAKI
author_sort HO, YUH-SHAN
collection PubMed
description This study was conducted to explore a bibliometric approach to quantitatively assess current research trends in cisplatin-containing chemotherapy for small cell lung cancer (SCLC), using related literature in the Science Citation Index Expanded database from 1992 to 2011. Articles were analyzed by the scientific output and research performances of countries and institutions. The distribution of key words in the article title and author-selected keywords were used to evaluate research trends. It was observed that the number of articles devoted to cisplatin-containing chemotherapy for SCLC did not increase with time. The USA and Japan were the top two countries with the highest number of articles devoted to cisplatin-containing chemotherapy for SCLC. In both countries, the number of articles did not increase with time, and a decreasing trend was identified in the USA over the last 10 years. This study demonstrates trends in cisplatin-containing chemotherapy for SCLC. The clinical application of novel drugs is required for successful SCLC treatment.
format Online
Article
Text
id pubmed-3573148
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-35731482013-02-15 Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded HO, YUH-SHAN NAKAZAWA, KENSUKE SATO, SHINYA TAMURA, TOMOHIRO KURISHIMA, KOICHI SATOH, HIROAKI Oncol Lett Articles This study was conducted to explore a bibliometric approach to quantitatively assess current research trends in cisplatin-containing chemotherapy for small cell lung cancer (SCLC), using related literature in the Science Citation Index Expanded database from 1992 to 2011. Articles were analyzed by the scientific output and research performances of countries and institutions. The distribution of key words in the article title and author-selected keywords were used to evaluate research trends. It was observed that the number of articles devoted to cisplatin-containing chemotherapy for SCLC did not increase with time. The USA and Japan were the top two countries with the highest number of articles devoted to cisplatin-containing chemotherapy for SCLC. In both countries, the number of articles did not increase with time, and a decreasing trend was identified in the USA over the last 10 years. This study demonstrates trends in cisplatin-containing chemotherapy for SCLC. The clinical application of novel drugs is required for successful SCLC treatment. D.A. Spandidos 2013-02 2012-11-15 /pmc/articles/PMC3573148/ /pubmed/23420619 http://dx.doi.org/10.3892/ol.2012.1029 Text en Copyright © 2013, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
HO, YUH-SHAN
NAKAZAWA, KENSUKE
SATO, SHINYA
TAMURA, TOMOHIRO
KURISHIMA, KOICHI
SATOH, HIROAKI
Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded
title Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded
title_full Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded
title_fullStr Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded
title_full_unstemmed Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded
title_short Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded
title_sort cisplatin for small cell lung cancer: associated publications in science citation index expanded
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573148/
https://www.ncbi.nlm.nih.gov/pubmed/23420619
http://dx.doi.org/10.3892/ol.2012.1029
work_keys_str_mv AT hoyuhshan cisplatinforsmallcelllungcancerassociatedpublicationsinsciencecitationindexexpanded
AT nakazawakensuke cisplatinforsmallcelllungcancerassociatedpublicationsinsciencecitationindexexpanded
AT satoshinya cisplatinforsmallcelllungcancerassociatedpublicationsinsciencecitationindexexpanded
AT tamuratomohiro cisplatinforsmallcelllungcancerassociatedpublicationsinsciencecitationindexexpanded
AT kurishimakoichi cisplatinforsmallcelllungcancerassociatedpublicationsinsciencecitationindexexpanded
AT satohhiroaki cisplatinforsmallcelllungcancerassociatedpublicationsinsciencecitationindexexpanded